Detalhe da pesquisa
1.
COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
Eur Respir J
; 51(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326333
2.
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial.
J Am Acad Dermatol
; 74(6): 1077-85, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26946985
3.
A clinical in-hospital prognostic score for acute exacerbations of COPD.
Respir Res
; 15: 99, 2014 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25158759
4.
High-risk patients following hospitalisation for an acute exacerbation of COPD.
Eur Respir J
; 42(4): 946-55, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349446
5.
Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.
Eur J Cancer
; 52: 181-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689864
6.
Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
J Thorac Oncol
; 6(2): 351-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21164367